Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia-Reference-Cited by-同舟云学术

Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia

Published:2013 Issue:1 Volume:14 Page:402
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Zakrzewska Joanna M,Palmer Joanne,Ettlin Dominik A,Obermann Mark,Giblin Gerard MP,Morisset Valerie,Tate Simon,Gunn Kevin

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Reference34 articles.

1. Prevalence of Trigeminal Autonomic Symptoms in Migraine: A Population-Based Study

2. 1. Trigeminal Neuralgia

3. Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia

4. Trigeminal Neuralgia

5. Diagnosis and Differential Diagnosis of Trigeminal Neuralgia

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PACAP inhibition alleviates neuropathic pain by modulating Nav1.7 through the MAPK/ERK signaling pathway in a rat model of chronic constriction injury;Neuropeptides;2023-06

2. Possible Strategies to Mitigate Placebo or Vehicle Response in Dry Eye Disease Trials: A Narrative Review;Ophthalmology and Therapy;2023-05-20

3. Oral lacosamide for the treatment of refractory trigeminal neuralgia: A retrospective analysis of 86 cases;Headache: The Journal of Head and Face Pain;2023-04

4. Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study;The Lancet Neurology;2022-11

5. A Review of Medical and Surgical Options for the Treatment of Facial Pain;Otolaryngologic Clinics of North America;2022-06